purpose investigate safety efficacy proton beam therapy aged patients hepatocellular carcinoma hcc methods materials patients aged NUMBER years hcc underwent proton beam therapy time irradiation patient age ranged NUMBER NUMBER years median NUMBER years hepatic tumors solitary NUMBER patients multiple NUMBER tumor size ranged NUMBER NUMBER mm median NUMBER mm maximum diameter NUMBER NUMBER patients received proton beam irradiation total doses NUMBER gy NUMBER fractions NUMBER gy NUMBER fractions NUMBER gy NUMBER fractions respectively according tumor location results irradiated tumors controlled period months median NUMBER months patients showed new hepatic tumors outside irradiated volume months treatment NUMBER lung metastasis local rates NUMBER NUMBER NUMBER years respectively NUMBER patients NUMBER died months treatment NUMBER patients died trauma old age NUMBER patient died hcc pneumonia arrhythmia overall survival rates NUMBER NUMBER NUMBER respectively toxicity grade NUMBER thrombocytopenia NUMBER patients observed conclusions proton beam therapy tolerable effective safe aged patients hcc contribute prolonged survival tumor control follow NUMBER NUMBER NUMBER NUMBER progression free disease free NUMBER NUMBER NUMBER year cause specific disease free therapy related